• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎残留肺部CT特征的定量分析:两款商业软件之间的一致性

Quantitative Analysis of Residual COVID-19 Lung CT Features: Consistency among Two Commercial Software.

作者信息

Granata Vincenza, Ianniello Stefania, Fusco Roberta, Urraro Fabrizio, Pupo Davide, Magliocchetti Simona, Albarello Fabrizio, Campioni Paolo, Cristofaro Massimo, Di Stefano Federica, Fusco Nicoletta, Petrone Ada, Schininà Vincenzo, Villanacci Alberta, Grassi Francesca, Grassi Roberta, Grassi Roberto

机构信息

Division of Radiology, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, 80131 Naples, Italy.

Radiology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.

出版信息

J Pers Med. 2021 Oct 28;11(11):1103. doi: 10.3390/jpm11111103.

DOI:10.3390/jpm11111103
PMID:34834455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8623042/
Abstract

OBJECTIVE

To investigate two commercial software and their efficacy in the assessment of chest CT sequelae in patients affected by COVID-19 pneumonia, comparing the consistency of tools.

MATERIALS AND METHODS

Included in the study group were 120 COVID-19 patients (56 women and 104 men; 61 years of median age; range: 21-93 years) who underwent chest CT examinations at discharge between 5 March 2020 and 15 March 2021 and again at a follow-up time (3 months; range 30-237 days). A qualitative assessment by expert radiologists in the infectious disease field (experience of at least 5 years) was performed, and a quantitative evaluation using thoracic VCAR software (GE Healthcare, Chicago, Illinois, United States) and a pneumonia module of ANKE ASG-340 CT workstation (HTS Med & Anke, Naples, Italy) was performed. The qualitative evaluation included the presence of ground glass opacities (GGOs) consolidation, interlobular septal thickening, fibrotic-like changes (reticular pattern and/or honeycombing), bronchiectasis, air bronchogram, bronchial wall thickening, pulmonary nodules surrounded by GGOs, pleural and pericardial effusion, lymphadenopathy, and emphysema. A quantitative evaluation included the measurements of GGOs, consolidations, emphysema, residual healthy parenchyma, and total lung volumes for the right and left lung. A chi-square test and non-parametric test were utilized to verify the differences between groups. Correlation coefficients were used to analyze the correlation and variability among quantitative measurements by different computer tools. A receiver operating characteristic (ROC) analysis was performed.

RESULTS

The correlation coefficients showed great variability among the quantitative measurements by different tools when calculated on baseline CT scans and considering all patients. Instead, a good correlation (≥0.6) was obtained for the quantitative GGO, as well as the consolidation volumes obtained by two tools when calculated on baseline CT scans, considering the control group. An excellent correlation (≥0.75) was obtained for the quantitative residual healthy lung parenchyma volume, GGO, consolidation volumes obtained by two tools when calculated on follow-up CT scans, and for residual healthy lung parenchyma and GGO quantification when the percentage change of these volumes were calculated between a baseline and follow-up scan. The highest value of accuracy to identify patients with RT-PCR positive compared to the control group was obtained by a GGO total volume quantification by thoracic VCAR (accuracy = 0.75).

CONCLUSIONS

Computer aided quantification could be an easy and feasible way to assess chest CT sequelae due to COVID-19 pneumonia; however, a great variability among measurements provided by different tools should be considered.

摘要

目的

研究两款商业软件及其在评估新冠病毒肺炎患者胸部CT后遗症方面的效果,比较工具之间的一致性。

材料与方法

研究组纳入了120例新冠病毒肺炎患者(56例女性和104例男性;中位年龄61岁;范围:21 - 93岁),这些患者于2020年3月5日至2021年3月15日出院时接受了胸部CT检查,并在随访期(3个月;范围30 - 237天)再次接受检查。由传染病领域至少有5年经验的放射科专家进行定性评估,并使用胸部VCAR软件(美国伊利诺伊州芝加哥通用电气医疗集团)和ANKE ASG - 340 CT工作站(意大利那不勒斯HTS Med & Anke)的肺炎模块进行定量评估。定性评估包括磨玻璃影(GGO)实变、小叶间隔增厚、纤维化样改变(网状影和/或蜂窝状影)、支气管扩张、空气支气管征、支气管壁增厚、GGO包绕的肺结节、胸腔和心包积液、淋巴结肿大以及肺气肿。定量评估包括测量左右肺的GGO、实变、肺气肿、残余健康实质和总肺容积。采用卡方检验和非参数检验来验证组间差异。相关系数用于分析不同计算机工具定量测量之间的相关性和变异性。进行了受试者操作特征(ROC)分析。

结果

在基线CT扫描并考虑所有患者时,不同工具的定量测量之间相关系数显示出很大变异性。相反,在考虑对照组时,对于定量GGO以及两款工具在基线CT扫描时获得的实变容积,获得了良好的相关性(≥0.6)。对于定量残余健康肺实质容积、GGO以及两款工具在随访CT扫描时获得的实变容积,以及在计算这些容积在基线和随访扫描之间的百分比变化时的残余健康肺实质和GGO定量,获得了极好的相关性(≥0.75)。通过胸部VCAR对GGO总体积进行定量,与对照组相比,识别RT - PCR阳性患者的准确率最高(准确率 = 0.75)。

结论

计算机辅助定量可能是评估新冠病毒肺炎胸部CT后遗症的一种简便可行的方法;然而,应考虑不同工具提供的测量结果之间存在很大变异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d3a/8623042/c76d9668bf60/jpm-11-01103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d3a/8623042/83879a1c59d0/jpm-11-01103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d3a/8623042/abeb40830f8a/jpm-11-01103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d3a/8623042/d97c0b68d9ff/jpm-11-01103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d3a/8623042/c76d9668bf60/jpm-11-01103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d3a/8623042/83879a1c59d0/jpm-11-01103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d3a/8623042/abeb40830f8a/jpm-11-01103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d3a/8623042/d97c0b68d9ff/jpm-11-01103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d3a/8623042/c76d9668bf60/jpm-11-01103-g004.jpg

相似文献

1
Quantitative Analysis of Residual COVID-19 Lung CT Features: Consistency among Two Commercial Software.新型冠状病毒肺炎残留肺部CT特征的定量分析:两款商业软件之间的一致性
J Pers Med. 2021 Oct 28;11(11):1103. doi: 10.3390/jpm11111103.
2
Chest CT Computerized Aided Quantification of PNEUMONIA Lesions in COVID-19 Infection: A Comparison among Three Commercial Software.胸部 CT 计算机辅助 COVID-19 感染性肺炎病变定量分析:三种商业软件比较
Int J Environ Res Public Health. 2020 Sep 22;17(18):6914. doi: 10.3390/ijerph17186914.
3
Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis.对 COVID-19 患者基线胸部 CT 上的临床和实验室数据、放射学结构化报告结果以及肺部受累的定量评估,以预测其预后。
Radiol Med. 2021 Jan;126(1):29-39. doi: 10.1007/s11547-020-01293-w. Epub 2020 Oct 12.
4
COVID-19 pneumonia: computer-aided quantification of healthy lung parenchyma, emphysema, ground glass and consolidation on chest computed tomography (CT).COVID-19 肺炎:胸部计算机断层扫描(CT)上健康肺实质、肺气肿、磨玻璃影和实变的计算机辅助定量。
Radiol Med. 2021 Apr;126(4):553-560. doi: 10.1007/s11547-020-01305-9. Epub 2020 Nov 18.
5
Evolution of CT Findings and Lung Residue in Patients with COVID-19 Pneumonia: Quantitative Analysis of the Disease with a Computer Automatic Tool.新型冠状病毒肺炎患者CT表现及肺残留灶的演变:使用计算机自动工具对疾病进行定量分析
J Pers Med. 2021 Jul 6;11(7):641. doi: 10.3390/jpm11070641.
6
Quantitative Chest CT analysis in discriminating COVID-19 from non-COVID-19 patients.定量胸部 CT 分析在鉴别 COVID-19 与非 COVID-19 患者中的应用。
Radiol Med. 2021 Feb;126(2):243-249. doi: 10.1007/s11547-020-01291-y. Epub 2020 Oct 12.
7
CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China.中国武汉 62 例 2019 年冠状病毒病(COVID-19)肺炎的 CT 特征。
AJR Am J Roentgenol. 2020 Jun;214(6):1287-1294. doi: 10.2214/AJR.20.22975. Epub 2020 Mar 5.
8
[Spatial and temporal distribution and predictive value of chest CT scoring in patients with COVID-19].新型冠状病毒肺炎患者胸部CT评分的时空分布及预测价值
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Mar 12;44(3):230-236. doi: 10.3760/cma.j.cn112147-20200522-00626.
9
Chest CT-based Assessment of 1-year Outcomes after Moderate COVID-19 Pneumonia.基于胸部 CT 的中度 COVID-19 肺炎 1 年后结局评估。
Radiology. 2022 Nov;305(2):479-485. doi: 10.1148/radiol.220019. Epub 2022 May 10.
10
CT imaging features of COVID-19 pneumonia: initial experience from Turkey.土耳其的 COVID-19 肺炎 CT 影像学特征:初步经验。
Diagn Interv Radiol. 2020 Jul;26(4):308-314. doi: 10.5152/dir.2020.20307.

引用本文的文献

1
Preliminary data on artificial intelligence tool in magnetic resonance imaging assessment of degenerative pathologies of lumbar spine.人工智能工具在腰椎退行性病变磁共振成像评估中的初步数据。
Radiol Med. 2024 Apr;129(4):623-630. doi: 10.1007/s11547-024-01791-1. Epub 2024 Feb 13.
2
Quantitative analysis of chest computed tomography of COVID-19 pneumonia using a software widely used in Japan.利用在日本广泛使用的软件对 COVID-19 肺炎的胸部计算机断层扫描进行定量分析。
PLoS One. 2023 Oct 23;18(10):e0287953. doi: 10.1371/journal.pone.0287953. eCollection 2023.
3
Radiomics and machine learning analysis by computed tomography and magnetic resonance imaging in colorectal liver metastases prognostic assessment.

本文引用的文献

1
Quantification of pulmonary involvement in COVID-19 pneumonia by means of a cascade of two U-nets: training and assessment on multiple datasets using different annotation criteria.通过两个 U-Net 级联对 COVID-19 肺炎肺部受累进行量化:使用不同标注标准在多个数据集上进行训练和评估。
Int J Comput Assist Radiol Surg. 2022 Feb;17(2):229-237. doi: 10.1007/s11548-021-02501-2. Epub 2021 Oct 26.
2
Artificial Intelligence and COVID-19 Using Chest CT Scan and Chest X-ray Images: Machine Learning and Deep Learning Approaches for Diagnosis and Treatment.利用胸部CT扫描和胸部X光图像的人工智能与COVID-19:用于诊断和治疗的机器学习与深度学习方法
J Pers Med. 2021 Sep 30;11(10):993. doi: 10.3390/jpm11100993.
3
基于计算机断层扫描和磁共振成像的影像组学与机器学习分析在结直肠癌肝转移预后评估中的应用
Radiol Med. 2023 Nov;128(11):1310-1332. doi: 10.1007/s11547-023-01710-w. Epub 2023 Sep 11.
4
Artificial intelligence and radiation effects on brain tissue in glioblastoma patient: preliminary data using a quantitative tool.人工智能和辐射对胶质母细胞瘤患者脑组织的影响:使用定量工具的初步数据。
Radiol Med. 2023 Jul;128(7):813-827. doi: 10.1007/s11547-023-01655-0. Epub 2023 Jun 8.
5
Qualitative and semi-quantitative ultrasound assessment in delta and Omicron Covid-19 patients: data from high volume reference center.德尔塔和奥密克戎新冠患者的定性和半定量超声评估:来自大容量参考中心的数据。
Infect Agent Cancer. 2023 May 27;18(1):34. doi: 10.1186/s13027-023-00515-w.
6
Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics.结直肠癌肝转移患者的预后评估:影像组学和影像基因组学的前景与局限
Infect Agent Cancer. 2023 Mar 16;18(1):18. doi: 10.1186/s13027-023-00495-x.
7
Radiation Recall Pneumonitis: The Open Challenge in Differential Diagnosis of Pneumonia Induced by Oncological Treatments.放射性回忆性肺炎:肿瘤治疗所致肺炎鉴别诊断中的公开挑战
J Clin Med. 2023 Feb 10;12(4):1442. doi: 10.3390/jcm12041442.
8
Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence.风险评估与胆管癌:诊断管理与人工智能
Biology (Basel). 2023 Jan 29;12(2):213. doi: 10.3390/biology12020213.
9
Immunotherapy Assessment: A New Paradigm for Radiologists.免疫疗法评估:放射科医生的新范例
Diagnostics (Basel). 2023 Jan 13;13(2):302. doi: 10.3390/diagnostics13020302.
10
Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence.风险评估与胰腺癌:诊断管理与人工智能
Cancers (Basel). 2023 Jan 5;15(2):351. doi: 10.3390/cancers15020351.
Using Artificial Intelligence for Automatic Segmentation of CT Lung Images in Acute Respiratory Distress Syndrome.
利用人工智能对急性呼吸窘迫综合征的CT肺图像进行自动分割
Front Physiol. 2021 Sep 14;12:676118. doi: 10.3389/fphys.2021.676118. eCollection 2021.
4
Plasma zinc status and hyperinflammatory syndrome in hospitalized COVID-19 patients: An observational study.住院 COVID-19 患者的血浆锌状态与高炎症综合征:一项观察性研究。
Int Immunopharmacol. 2021 Nov;100:108163. doi: 10.1016/j.intimp.2021.108163. Epub 2021 Sep 20.
5
Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection.镰状细胞特征对 SARS-CoV-2 感染发病率和死亡率的影响。
Blood Adv. 2021 Sep 28;5(18):3690-3693. doi: 10.1182/bloodadvances.2021004977.
6
Structured Reporting of Lung Cancer Staging: A Consensus Proposal.肺癌分期的结构化报告:一项共识提案。
Diagnostics (Basel). 2021 Aug 30;11(9):1569. doi: 10.3390/diagnostics11091569.
7
Preliminary Report on Computed Tomography Radiomics Features as Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients.计算机断层扫描影像组学特征作为肺腺癌患者免疫治疗选择生物标志物的初步报告
Cancers (Basel). 2021 Aug 7;13(16):3992. doi: 10.3390/cancers13163992.
8
Cross-Site Severity Assessment of COVID-19 From CT Images via Domain Adaptation.基于域自适应的 CT 图像 COVID-19 跨站点严重程度评估
IEEE Trans Med Imaging. 2022 Jan;41(1):88-102. doi: 10.1109/TMI.2021.3104474. Epub 2021 Dec 30.
9
Evolution of CT Findings and Lung Residue in Patients with COVID-19 Pneumonia: Quantitative Analysis of the Disease with a Computer Automatic Tool.新型冠状病毒肺炎患者CT表现及肺残留灶的演变:使用计算机自动工具对疾病进行定量分析
J Pers Med. 2021 Jul 6;11(7):641. doi: 10.3390/jpm11070641.
10
Post-Acute Sequelae of COVID-19 Pneumonia: Six-month Chest CT Follow-up.新型冠状病毒肺炎的急性后遗症:胸部CT六个月随访
Radiology. 2021 Nov;301(2):E396-E405. doi: 10.1148/radiol.2021210834. Epub 2021 Jul 27.